Literature DB >> 3275892

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation.

C East, P A Alivizatos, S M Grundy, P H Jones, J A Farmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275892     DOI: 10.1056/NEJM198801073180111

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.

Authors:  E Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 2.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Tacrolimus/cerivastatin interaction study in liver transplant recipients.

Authors:  W Mück; D A Neal; O Boix; B Voith; R Hasan; G J Alexander
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 4.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 5.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 7.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

8.  Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.

Authors:  T Koga; T Kikuchi; A Miyazaki; H Koike
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

9.  [Severe rhabdomyolysis in a patient receiving lovastatin, danazol, and doxycycline].

Authors:  M Dallaire; M Chamberland
Journal:  CMAJ       Date:  1994-06-15       Impact factor: 8.262

Review 10.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.